Keywords: novartis, sandostatin, lar, depot, approved, fda, pharmaceuticals

Novartis' Sandostatin LAR Depot Approved By FDA

Article | 02 December 1998

Novartis Pharmaceuticals has received approval from the US Food and DrugAdministration to market Sandostatin LAR Depot (octreotide acetate injectable suspension) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Octreotide Acetate

Sandostatin

Octreotide Acetate Injection

Sandostatin LAR

Humulin 70-30

Go to drug listing